From: Analysis of inter-patient variations in tumour growth rate
Tumour type | Reference | n | R2 | p (1-tailed) | Median time interval (days) | Median time interval/DTe | Average SGR (%/d) | Relative uncertainty of SGR (%) | DTe (days) | Relative uncertainty of volume estimation (%) |
---|---|---|---|---|---|---|---|---|---|---|
Meningioma | Nakamura et al.[29] | 41 | 0.2424 | 0.0005 | 1230 | 0.71 | 0.04 | 105 | 1733 | 37 |
Hepatocellular carcinoma | Nakajima et al.[27] | 34 | 0.038 | NS (0.13) | 128 | 2.4 | 1.30 | 73 | 53 | 86 |
Saito et al.[28] | 21 | 0.0623 | NS (0.14) | 146 | 1.05 | 0.50 | 47 | 139 | 24 | |
Taouli et al.[26] | 16 | 0.0014 | NS (0.89) | NA | NA | 0.90 | 115 | 77 | NA | |
Pancreatic carcinoma | Furukawa et al.[25] | 9 | 0.0248 | NS (0.34) | 295 | 2.13 | 0.50 | 58 | 139 | 60 |
Primary Lung Cancer | Wang et al.[24] | 12 | 0.1619 | NS (0.19) | 365 | 4.21 | 0.80 | 36 | 87 | 74 |
El Sharouni et al.[23] | 18 | 0.2713 | 0.026 | 48 | 1.94 | 2.80 | 73 | 25 | 69 | |
REGROWTH |